Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
16
|
pubmed:dateCreated |
1997-9-10
|
pubmed:abstractText |
We report the synthesis, octanol/water partition coefficient (log P), dissociation constants (pKa), H3-receptor affinity (pKi in rat brain membranes, [3H]-N alpha-methylhistamine), and H3-antagonist potency (pA2 in guinea ileum, (R)-alpha-methylhistamine) of novel H3-receptor antagonists obtained by introducing a para or meta substituent on the phenyl ring of the lead compound 4(5)-phenyl-2-[[2-[4(5)-imidazolyl]ethyl]thio]imidazole (3a). The substituents were chosen to obtain broad and uncorrelated variation in their lipophilic, electronic, and steric properties. The log P values of the neutral species cover almost 3 orders of magnitude (from 1.40 to 4.11). The pKa,2 values (protonation of the 2-thioimidazole fragment) vary from 3.13 to 4.34, indicating that this fragment, which incorporates the so-called polar group common to many H3-receptor antagonists, is neutral at physiological pH. The compounds had pKi values in a range too narrow (from 7.28 to 8.03) to derive QSAR equations. In one case (3g), a biphasic displacement curve was observed (pKi,1 = 8.53; pKi,2 = 6.90). The pA2 values ranged 2 orders of magnitude (from 6.83 to 8.87) and yielded a QSAR model (PLS) indicating that antagonist potency depends parabolically on lipophilicity and is decreased by bulky para substituents. The compounds of this series, therefore, maintain a fair-to-good affinity for rat brain H3-receptor and a fair-to-good H3-antagonist potency on guinea pig ileum, although varying markedly in their lipophilicity. The series thus appears as a good candidate for pharmacokinetic optimization leading to brain-penetrating H3-receptor antagonists.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Dimaprit,
http://linkedlifedata.com/resource/pubmed/chemical/Histamine Antagonists,
http://linkedlifedata.com/resource/pubmed/chemical/Imidazoles,
http://linkedlifedata.com/resource/pubmed/chemical/Methylhistamines,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Histamine H3,
http://linkedlifedata.com/resource/pubmed/chemical/alpha-methylhistamine
|
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0022-2623
|
pubmed:author |
pubmed-author:BallabeniVV,
pubmed-author:BarocelliEE,
pubmed-author:BordeJJ,
pubmed-author:CarettaAA,
pubmed-author:CarruptP APA,
pubmed-author:CrivoriPP,
pubmed-author:ImpicciatoreMM,
pubmed-author:MolWW,
pubmed-author:PlazziP VPV,
pubmed-author:RivaraSS,
pubmed-author:SilvaCC,
pubmed-author:TestaBB
|
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
40
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2571-8
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:9258364-Animals,
pubmed-meshheading:9258364-Binding, Competitive,
pubmed-meshheading:9258364-Cerebral Cortex,
pubmed-meshheading:9258364-Dimaprit,
pubmed-meshheading:9258364-Electric Stimulation,
pubmed-meshheading:9258364-Evoked Potentials,
pubmed-meshheading:9258364-Guinea Pigs,
pubmed-meshheading:9258364-Histamine Antagonists,
pubmed-meshheading:9258364-Ileum,
pubmed-meshheading:9258364-Imidazoles,
pubmed-meshheading:9258364-Methylhistamines,
pubmed-meshheading:9258364-Rats,
pubmed-meshheading:9258364-Rats, Wistar,
pubmed-meshheading:9258364-Receptors, Histamine H3,
pubmed-meshheading:9258364-Structure-Activity Relationship
|
pubmed:year |
1997
|
pubmed:articleTitle |
H3-receptor antagonists: synthesis and structure-activity relationships of para- and meta-substituted 4(5)-phenyl-2-[[2-[4(5)-imidazolyl]ethyl]thio]imidazoles.
|
pubmed:affiliation |
Dipartimento Farmaceutico, Università degli Studi di Parma, Italy.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|